Genetic and Molecular Characteristics of Mexican Adults With Acute Myeloid Leukemia: a Prospective Multicentric Study.

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 22, 2020

Primary Completion Date

September 30, 2025

Study Completion Date

October 31, 2025

Conditions
Acute Myeloid Leukemia
Interventions
DIAGNOSTIC_TEST

Molecular panel

"* Detection of CBF rearrangements using PCR: CBFB-MYH11 \[inv(16)(p13;q22), isoforms A, E and D; AML-ETO (RUNX1-RUNX1T1) (t8;21)(q22;q22).~* NGS panel to detect classic mutations in: FLT3-ITD and TKD, NPM1, CEBPA, RUNX1, TP53, ASXL1, IDH1, IDH2 and KIT"

Trial Locations (10)

1400

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City

Unknown

Hospital Regional de Alta Especialidad Ixtapaluca, Ixtapaluca

Hospital Regional de Alta Especialidad Bajío, León

Hospital Universitario, Monterrey

Imss Umae 25, Monterrey

Hospital Regional de Alta Especialidad Ciudad Victoria, Ciudad Victoria

Centro Médico Naciona Siglo XXI IMSS, Mexico City

Hospital General de México, Mexico City

Hospital Juarez de México, Mexico City

Instituto Nacional de Cancerlogía, Mexico City

All Listed Sponsors
collaborator

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

OTHER

collaborator

Instituto Nacional de Cancerologia de Mexico

OTHER

collaborator

Centro Medico Nacional Siglo XXI IMSS

OTHER

collaborator

Hospital General de México Dr. Eduardo Liceaga

OTHER_GOV

collaborator

Hospital Regional de Alta Especialidad del Bajio

OTHER

collaborator

Instituto Mexicano del Seguro Social

OTHER_GOV

collaborator

Hospital Universitario Dr. Jose E. Gonzalez

OTHER

collaborator

Hospital Regional de Alta Especialidad de Ciudad Victoria Bicentenario 2010

OTHER

collaborator

Hospital Juarez de Mexico

OTHER_GOV

collaborator

Hospital Regional de Alta especialidad de Ixtapaluca

OTHER

lead

Mexican Agrupation for Hematology Study

OTHER